Mehdi Hamadani Selected Research

Cell Transplantation

11/2022	Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients.
7/2022	Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
1/2022	Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics.
1/2022	Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit.
1/2022	Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma.
12/2021	Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
12/2021	ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma.
11/2021	The impact of beta-blocker use at the time of hematopoietic cell transplantation on the development of acute and chronic graft-versus-host disease.
11/2021	Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
11/2021	Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehdi Hamadani Research Topics

Disease

38	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 10/2008
35	Lymphoma (Lymphomas) 01/2022 - 12/2007
34	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 12/2006
30	Multiple Myeloma 01/2022 - 03/2008
27	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2009
23	Neoplasms (Cancer) 01/2022 - 06/2007
18	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2021 - 03/2009
17	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2018 - 10/2008
16	Hodgkin Disease (Hodgkin's Disease) 12/2021 - 10/2015
15	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2008
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 05/2008
11	B-Cell Lymphoma (Lymphoma, B Cell) 07/2022 - 11/2008
7	Infections 12/2020 - 11/2009
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 04/2017
6	Amyloidosis 12/2019 - 12/2014
6	Leukemia 09/2017 - 04/2008
5	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2014
5	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 04/2008
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 04/2008
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2020 - 01/2016
4	Neutropenia 01/2022 - 12/2014
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2021 - 03/2016
4	Nausea 01/2021 - 06/2006
3	Bronchiolitis Obliterans Syndrome 11/2021 - 01/2020
3	Cytokine Release Syndrome 11/2021 - 01/2018
3	Disease Progression 06/2021 - 01/2016
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 01/2016
3	Pathologic Complete Response 01/2021 - 02/2014
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 01/2017
3	Fatigue 01/2021 - 11/2017
3	Cytopenia 05/2020 - 09/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 03/2015
3	Immunoglobulin Light-chain Amyloidosis 12/2019 - 12/2014
3	Mucositis 01/2019 - 01/2017
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2022 - 01/2017
2	cell-associated neurotoxicity 01/2022 - 12/2021
2	Fever (Fevers) 10/2021 - 01/2019
2	Diarrhea 10/2021 - 12/2006
2	Exanthema (Rash) 10/2021 - 12/2006
2	Edema (Dropsy) 01/2021 - 11/2017
2	COVID-19 12/2020 - 01/2020
2	Splenomegaly 01/2020 - 09/2012
2	Thrombotic Microangiopathies 01/2020 - 11/2017
2	Primary Myelofibrosis (Myelosclerosis) 01/2020 - 01/2014
2	Hemorrhage 10/2019 - 03/2007

Drug/Important Bio-Agent (IBA)

15	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 07/2012
14	Chimeric Antigen ReceptorsIBA 07/2022 - 12/2019
12	Rituximab (Mabthera)FDA Link 11/2021 - 12/2007
8	loncastuximab tesirineIBA 01/2022 - 12/2019
8	Calcineurin InhibitorsIBA 10/2020 - 02/2016
7	Pharmaceutical PreparationsIBA 06/2021 - 12/2006
7	plerixafor FDA Link 12/2019 - 01/2012
6	SteroidsIBA 11/2021 - 12/2006
6	Monoclonal AntibodiesIBA 01/2021 - 07/2008
6	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 01/2018
6	Busulfan (Busulfex)FDA Link 01/2020 - 12/2013
6	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 11/2009
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2019 - 01/2012
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 06/2007
6	Lenalidomide (CC 5013)FDA Link 01/2019 - 12/2014
5	fludarabineIBA 10/2020 - 01/2018
5	ixazomibIBA 10/2020 - 12/2014
5	ibrutinibIBA 01/2020 - 10/2015
5	Proteasome InhibitorsIBA 01/2020 - 12/2014
5	Bortezomib (Velcade)FDA Link 01/2019 - 12/2014
4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 12/2019
4	ruxolitinibIBA 11/2021 - 01/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020 - 12/2006
4	Biological ProductsIBA 12/2017 - 01/2016
3	axicabtagene ciloleucelIBA 01/2022 - 12/2019
3	Propranolol (Inderal)FDA LinkGeneric 01/2022 - 05/2018
3	Anaplastic Lymphoma KinaseIBA 01/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2015
2	EnzymesIBA 01/2022 - 01/2021
2	tisagenlecleucelIBA 01/2022 - 12/2019
2	Brentuximab VedotinIBA 12/2021 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 07/2021 - 01/2020
2	Immunomodulating AgentsIBA 01/2020 - 10/2017
2	Alemtuzumab (Campath)FDA Link 01/2020 - 09/2013
2	thymoglobulin FDA Link 01/2019 - 11/2009
2	Amyloid (Amyloid Fibrils)IBA 06/2018 - 12/2017
2	Antineoplastic Agents (Antineoplastics)IBA 05/2018 - 01/2011
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2018 - 01/2018
2	Atorvastatin (Lipitor)FDA Link 08/2017 - 12/2013
2	Ifosfamide FDA LinkGeneric 10/2016 - 12/2006
2	Carboplatin (JM8)FDA LinkGeneric 10/2016 - 06/2007
2	posaconazole FDA Link 08/2015 - 12/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2014 - 10/2013

Therapy/Procedure

116	Cell Transplantation 11/2022 - 01/2011
72	Therapeutics 02/2022 - 12/2006
40	Transplantation 01/2022 - 07/2008
26	Homologous Transplantation 01/2022 - 04/2008
19	Drug Therapy (Chemotherapy) 01/2022 - 06/2006
14	Autologous Transplantation 02/2022 - 09/2013
13	Hematopoietic Stem Cell Transplantation 01/2020 - 04/2008
9	Stem Cell Transplantation 01/2022 - 07/2008
6	Immunotherapy 01/2022 - 11/2014
6	Salvage Therapy 01/2021 - 01/2016
3	Haploidentical Transplantation 10/2019 - 01/2018
2	Secondary Prevention 11/2018 - 01/2018